1. Digoxin and association with mortality in patients discharged from hospital with atrial fibrillation, with or without heart failure. (24th May 2021) Authors: Mpotis, M; Kartas, A; Samaras, A; Akrivos, E; Vrana, E; Liampas, E; Papazoglou, A; Moysidis, D; Papanastasiou, A; Baroutidou, A; Karvounis, H; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Polypharmacy and major adverse events in atrial fibrillation. (24th May 2021) Authors: Tsagkaris, C; Kartas, A; Samaras, A; Papazoglou, A; Moysidis, D; Vrana, E; Vouloagkas, I; Papanastasiou, A; Kotzampasis, G; Baroutidou, A; Karagiannidis, E; Louka, A-M; Matiashova, L; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Predictive role of platelet indices on hospital admission and discharge in the long-term prognosis of acute coronary syndrome: Platelets do count. (11th May 2021) Authors: Psarakis, G; Farmakis, I; Zafeiropoulos, S; Tsolakidis, C; Konstantas, O; Kourti, O; Touriki, AB; Psathas, T; Vrana, E; Graidis, S; Spyridaki, K; Daniilidou, A; Baroutidou, A; Karvounis, H; Giannakoulas, G Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictors of all-cause mortality within and beyond 1 year after an acute coronary syndrome. (11th May 2021) Authors: Zafeiropoulos, S; Farmakis, IT; Kartas, A; Psarakis, G; Kourti, O; Tsolakidis, C; Konstantas, O; Touriki, A; Baroutidou, A; Vrana, E; Graidis, S; Psathas, T; Miyara, SJ; Karvounis, H; Giannakoulas, G Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation. (14th October 2021) Authors: Samaras, A; Vrana, E; Kartas, A; Rampidis, G; Doundoulakis, I; Fotos, G; Efthimiadis, G; Karvounis, H; Tzikas, A; Giannakoulas, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic significance of diabetes mellitus in patients with atrial fibrillation. (24th May 2021) Authors: Papazoglou, A; Kartas, A; Samaras, A; Vouloagkas, I; Vrana, E; Moysidis, D; Akrivos, E; Kotzampasis, G; Papanastasiou, A; Baroutidou, A; Botis, M; Tsagkaris, C; Karagiannidis, E; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Right ventricular myocardial work characterisation in patients with pulmonary hypertension: association with invasive haemodynamic parameters. (14th October 2021) Authors: Butcher, S C; Feloukidis, C; Kamperidis, V; Stassen, J; Fortuni, F; Vrana, E; Mouratoglou, S A; Boutou, A; Giannakoulas, G; Playford, D; Ajmone Marsan, N; Bax, J J; Delgado, V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗